Comorbidities Flashcards
(53 cards)
Right to Left Shunts
Tetralogy of Falot (VSOR) Transposition of the Great Vessels Truncus Arteriosus Tricuspid Atresia Total Anomalous Return
Causes of HTN
CKD Renovascular disease Chronic steroid therapy OSA Drugs (cocaine, amphetamine, supplements, OCPs) EtOH abuse Obesity Metabolic syndrome Thyroid/parathyroid disease Pheochromocytoma Coarctation of the aorta
Signs of end-organ damage from HTN
LVH Angina MI CHF CAD Stroke TIA CKD Retinopathy PAD
Diabetes Insipidus
Central (no ADH) vs Nephrogenic (unresponsive to ADH)
Tests: Urine specific gravity, serum osm, serum/urine lytes
Increased serum Na and osm
Urine specific gravity is low (<1.005)
Urine osm increases with ADH administration (CDI)
Txt:
- fluid replacement (D5W, 1/2NS at maintenance plus 2/3 previous hours UOP)
- desmopressin (DDAVP)
Lithium: signs of toxicity, drugs to avoid, anesthetic effects
skeletal muscle weakness, cognitive changes (sedation), ataxia, widening QRS, AV heart block, hypotension, seizures; avoid thiazides, NSAIDS, ACEIs; administer Na containing fluids to prevent excessive renal reabsorption of lithium; reduces anesthetic requirements and prolongs depol NMBs and nondepol NMBs
Optimization of thyroid status
endocrine consult, continue PTU (inhibits organification of iodide, synthesis of thyroid hormone, and peripheral conversion of T4 to T3), give propranolol (txt hyperadrenergic state and peripheral conversion of T4 to T3), give steroid (reduce hormone release and conversion), optimize hydration, correct electrolyte abnormalities, prepare to treat HD instability, arrhythmias, and thyroid storm
RA systemic manifestations
Due to vasculitis that develops secondary to deposition of immune complexes: pericardial thickening, pericardial effusion, pericarditis, myocarditis, aortitis, cardiac valve fibrosis, myocardial ischemia, diastolic dysfunction, pulmonary hypertension, dysrhythmias, pleural effusions, pulmonary fibrosis, interstitial lung disease, peripheral neuropathy (CTS), liver dysfunction, kidney dysfunction, mild anemia, joint disease (affecting airway). Commonly associated with Sjogren syndrome (keratoconjunctivitis and xerostomia).
RA Txt
NSAIDs, steroids, DMARDs ( methotrexate, sulfasalazine, azathioprine)
Hypothermia
coagulopathy, cardiac dysrhythmias, impaired renal function, poor wound healing; dec CMRO2 by 7%/C below 36C
GCS
MoVE: 6, 5, 4
Motor (obeys, localizes, withdraws, decort, decereb, none)
Voice (oriented, confused, inappropriate, incomprehensible, none)
Eyes (spont, speech, pain, none)
3-15; 0-8 severe, 9-12 mod, 13-15 mild
ARDS
pulmonary manifestation of SIRS; injury to capillary alveolar membrane
Berlin Criteria:
1) P/F ratio <300 (mild 200-300, mod 100-200, sev <100)
2) acute onset (<7d)
3) bilateral infiltrates
4) resp failure (“not fully exp by cardiac failure or fluid overload”)
OSA
inc risk of perioperative complications: resp depression, airway obstruction, hypoxia, hypercarbia
AHI >30 severe, 16-30 mod, 5-15 mild
- require longer postop stay for monitoring (3h longer than non-OSA patients)
- keep for 7h after the last episode of airway obstruction or hypoxemia
- use CPAP/NIPPV in PACU if patient uses at home
RCRI
1) IDDM
2) Hx of MI
3) Hx of CHF
4) Hx of CVD
5) CKD (Cr >2)
6) High risk surgery (suprainguinal vascular, intraperitoneal, intrathoracic
Risk of MACE: 0=4% 1=6% 2=10% >2=15%
Preeclampsia
Mild:
1) SBP >/=140 or DBP >/=90 on 2 readings 4h apart
2) proteinuria (24h Upr >/=300 or P:C 0.3)
3) >20 WGA
Severe:
1) SBP >/= 160 or DBP >/= 110
2) renal insufficiency (Cr >1.1 or doubled)
3) CNS disturbance (HA, vision change)
4) pulmonary edema
5) liver dysfunction (ALT/AST doubles)
6) epigastric or RUQ pain
7) thrombocytopenia
methemoglobinemia
SpO2 = 85%
Causes: benzocaine, prilocaine, other oxidizers
Level >10% can lead to cyanotic appearance
<30% - no tissue hypoxia
30-50% - signs and symptoms of tissue hypoxia
>50% - coma or death possible
Txt: 100% O2 + exchange transfusion vs methylene blue (2mg/kg over 3-5 min; repeat after 30min; NOT in G6PD def)
MG vs LEMS
MG:
- Ab to post-synaptic nAChR
- ext weakness +/- bulbar symptoms (diplopia, ptosis, dysphagia, dysarthria)
- cardiac manifestations as well (HTN, AV block, Afib, myocarditis, cardiomyopathy)
- txt w/ AChE inh to inc Ach
- resistant to Sux (1.5-2mg/kg)
- sensitive to NDMR (red dose 1/2)
- associated w/ thymoma, hyperthyroidism, pernicious anemia, RA, SLE, neonatal muscle weakness
LEMS:
- Ab to pre-synaptic Ca channel preventing release of ACh
- weakness
- sensitive to depolarizing and nondepolarizing NMBs
Edrophonium (tensilon) test - diagnosis of MG and differentiate MG exacerbation from cholinergic crisis
CSW vs SIADH
CSW: hypovolemic, nml ADH, UNa >100, Uosm low or normal, polyuria
SIADH: euvolemic, inc ADH, UNA <100, Uosm high, decreased UO
Txt for CSW: fluid replacement, no diuresis
Txt for SIADH: water restriction, diuresis, demeclocycline, Na replacement
Extubation Criteria
TV >5ml/kg VC >10ml/kg SpO2 >90% on <50% FiO2 PaCO2 <50 PEEP =5 awake and cooperative intact airway reflexes
Smoking cessation
- reduced COHb
- dec nicotine effects on CV system
- improved mucous clearance/ciliary function
- 4 wks needed to dec risk of postop pulm complications
- 8 wks needed for risk to equal non-smoker
- may lead to permanent cessation
TRALI
1) acute onset of hypoxemia w/in 6h of transfusion
2) chest infiltrates w/out cardiomegaly
3) no evidence of atrial HTN (i.e. PAWP =18)
4) no preexisting ALI before transfusion
5) no other temporally related causes of ALI
- noncardiogenic pulmonary edema
- plasma containing blood products (WB, FFP, Plt, PRBCs)
- fever, chills, hypotension
- intrinsic inflammatory response w/in the lungs
DMD
-abnormal production of dystrophin
CV: cardiomyopathy, ventricular dysrhythmias, MR, pulm HTN, cor pulmonale, JVD, LE edema
RESP: wheezing, pulm edema, nocturnal desat and sleep apnea -> pulm HTN
AIRWAY: macroglossia
NEURO: possible neuro deficits, weakness
GI: delayed gastric emptying, diminished laryngeal reflexes
ENDO: chronic steroid use to inc muscle mass
**NOT considered associated with MH but administering sux to DMD patients can cause hyperkalemia and rhabdomyolysis (avoid sux in children =8yo)
Obesity
- airway management
- patient positioning
- pulmonary abnormalities (atelectasis, hypoxia, dec FRC, inc CC, rapid desat)
- OHS/OSA
- postop apnea
- metabolic syndrome (DM, HTN)
- CAD
- stroke
- DVT/PE
- OA
- NAFLD
- altered drug effects
Aortic Dissection
- massive hemorrhage
- propagation
- interruption of arteries arising from the aorta (end organ ischemia - cerebral, renal, coronary, mesenteric)
- spinal cord ischemia
- myocardial ischemia 2/2 HD effects of clamping
- renal insufficiency/failure
- respiratory failure
DeBakey:
Type I - asc aorta + thoracic or abdominal aorta
Type II - asc aorta only (not beyond the innominate)
Type IIIa - desc aorta to diaphragm
Type IIIb - desc aorta to aorto-iliac bifurcation
Stanford:
Type A - asc aorta +/- arch and desc aorta (Type I & II)
Type B - all cases where asc aorta not involved (Type III)
HTN
hemodynamic instability, CVA, MI, acute CHF, resp failure